LOS ANGELES…June 17, 2021 — Craig Lipset, a clinical trials industry innovator and leader, has joined the MedVector team as a new board member and executive advisor. MedVector’s novel Prime-Control Technology platform unlocks access to millions of potential clinical trial participants who are seen every day by physicians who are not seeking to become study…
Among the myriad equity crowdfunding platforms — which allow anyone to invest in startups — you can choose from, StartEngine is one of the leaders. A critical factor has been the company’s early mover advantage in the industry. But StartEngine has also been innovating. For example, the company recently rolled out a secondary trading platform.…
MedVector introduces its Prime-Controltm Technology to provide contract research organizations and pharmaceutical sponsors with access to subjects for new clinical trials. FREMONT, CA: MedVector has begun a nationwide rollout of its Prime-Controltm Technology, which will provide contract research organizations (CROs) and pharmaceutical sponsors with access to numerous patients without the requirement of new clinical trial sites.…
Last year, pharmaceutical giant Gilead Sciences came under fire for testing its coronavirus vaccine on a sample of people that didn’t accurately reflect those largely devastated by it — the elderly, the poor and Latino communities. The scenario exposed a deeper trouble among drugmakers and is far from uncommon. A study last month from the…
March 25, 2021 – MedVector has begun the rollout of its Prime-Controltm Technology, to give contract research organizations (CROs) and pharma sponsors access to patients without triggering new clinical trial sites. MedVector is the only company that partners with CROs, sponsors, and patient recruitment companies to expand subject participation beyond existing clinical trial sites. Clinical…
